Literature DB >> 1640029

Systemic and endotracheal antibiotic prophylaxis of nosocomial pneumonia in ICU.

H Lode1, G Höffken, B Kemmerich, T Schaberg.   

Abstract

Nosocomial pneumonias, especially in ventilated patients, are a continuing problem in modern medicine. Pathogens most commonly involved with these pneumonias are Enterobacteriaceae, Ps. aeruginosa and S. aureus. Several prevention measures for nosocomial pneumonia are possible such as parenteral and topical antibiotics--a very controversial issue. Several studies with parenteral antibiotics, starting as early as 1954, could not prove any benefit of parenteral antibiotics in pneumonia prevention. Topical antibiotics, starting with polymyxin or gentamicin via the endotracheal tube in the 70s, gave controversial results. In a prospective, randomized, double-blind placebo controlled study with gentamicin via the endotracheal tube in ventilated ICU patients we found no significant reduction of pneumonia rate and mortality. However, the combined approach (SDD) of oropharyngeal, gastrointestinal and parenteral use of certain antibiotics appears to give promising results in specific patient subgroups such as ventilated polytrauma patients in ICU.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1640029     DOI: 10.1007/bf01752973

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  29 in total

1.  A study of antibiotic prophylaxis in unconscious patients.

Authors:  R G PETERSDORF; J A CURTIN; P D HOEPRICH; R N PEELER; I L BENNETT
Journal:  N Engl J Med       Date:  1957-11-21       Impact factor: 91.245

2.  Aerosol polymyxin and pneumonia in seriously ill patients.

Authors:  T W Feeley; G C Du Moulin; J Hedley-Whyte; L S Bushnell; J P Gilbert; D S Feingold
Journal:  N Engl J Med       Date:  1975-09-04       Impact factor: 91.245

Review 3.  Ventilator-associated pneumonia in patients with respiratory failure. A diagnostic approach.

Authors:  G U Meduri
Journal:  Chest       Date:  1990-05       Impact factor: 9.410

4.  Prevention of nosocomial pneumonia using topical and parenteral antimicrobial agents.

Authors:  W G Johanson; J J Seidenfeld; R de los Santos; J J Coalson; P Gomez
Journal:  Am Rev Respir Dis       Date:  1988-02

5.  Endotracheally administered gentamicin for the prevention of infections of the respiratory tract in patients with tracheostomy: a double-blind study.

Authors:  J Klastersky; E Huysmans; D Weerts; C Hensgens; D Daneau
Journal:  Chest       Date:  1974-06       Impact factor: 9.410

6.  The nationwide nosocomial infection rate. A new need for vital statistics.

Authors:  R W Haley; D H Culver; J W White; W M Morgan; T G Emori
Journal:  Am J Epidemiol       Date:  1985-02       Impact factor: 4.897

7.  Prospective trials of dexamethasone and aerosolized gentamicin in the treatment of inhalation injury in the burned patient.

Authors:  B A Levine; P A Petroff; C L Slade; B A Pruitt
Journal:  J Trauma       Date:  1978-03

8.  Role of fibronectin in the prevention of adherence of Pseudomonas aeruginosa to buccal cells.

Authors:  D E Woods; D C Straus; W G Johanson; J A Bass
Journal:  J Infect Dis       Date:  1981-06       Impact factor: 5.226

9.  [Prophylaxis and treatment of respiratory tract infection in ventilated patients by endotracheal administration of aminoglycosides (author's transl)].

Authors:  F Vogel; H Werner; M Exner; M Marx
Journal:  Dtsch Med Wochenschr       Date:  1981-07-10       Impact factor: 0.628

10.  Prevention of pneumonia in an intensive care unit: a randomized multicenter clinical trial. Intensive Care Unit Group of Infection Control.

Authors:  M Mandelli; P Mosconi; M Langer; M Cigada
Journal:  Crit Care Med       Date:  1989-06       Impact factor: 7.598

View more
  4 in total

Review 1.  Aerosolised antibacterials for the prevention and treatment of hospital-acquired pneumonia.

Authors:  G Christopher Wood; Joseph M Swanson
Journal:  Drugs       Date:  2007       Impact factor: 9.546

2.  Bacterial keratitis in the critically ill.

Authors:  B Parkin; A Turner; E Moore; S Cook
Journal:  Br J Ophthalmol       Date:  1997-12       Impact factor: 4.638

3.  Pre-emptive broad-spectrum treatment for ventilator-associated pneumonia in high-risk patients.

Authors:  Emilio Bouza; María Jesús Pérez Granda; Javier Hortal; José M Barrio; Emilia Cercenado; Patricia Muñoz
Journal:  Intensive Care Med       Date:  2013-06-28       Impact factor: 17.440

4.  Administration of antibiotics via the respiratory tract for the prevention of ICU-acquired pneumonia: a meta-analysis of comparative trials.

Authors:  Matthew E Falagas; Ilias I Siempos; Ioannis A Bliziotis; Argyris Michalopoulos
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.